Biodistribution, excretion and effective half-life for 89Zr-girentuximab: preliminary results

Physica Medica 2026

View at publisher

Authors: G. Colelli, Anna Piai, Alessandro Loria, D. Tosoni, Bianca Bordigoni, P. Gelardi, Lidija Antunovic, A. Chiti, A. Del Vecchio

DOI: 10.1016/j.ejmp.2025.105292

Cited by: 0

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Medical Imaging Techniques and Applications Renal cell carcinoma treatment